LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sensor Technology Can Improve Accuracy of Prostate Cancer Diagnosis

By LabMedica International staff writers
Posted on 22 Jul 2015
Print article
Image: The SR7500DC Dual Channel Surface Plasmon Resonance System (Photo courtesy of Reichert).
Image: The SR7500DC Dual Channel Surface Plasmon Resonance System (Photo courtesy of Reichert).
A smart sensor chip that is able to pick up on subtle differences in glycoprotein molecules can improve the accuracy and efficiency of prostate cancer diagnosis.

Glycoprotein molecules, proteins that are covalently bound to one or more carbohydrate chains, perform a wide range of functions in cell surfaces, structural tissues and blood and because of their essential role in our immune response, they are useful clinical biomarkers for detecting prostate cancer and other diseases.

Chemists at the University of Birmingham (Edgbaston, UK) created a sensor chip with synthetic receptors along a two dimensional surface to identify specific, targeted glycoprotein molecules that are differentiated by their modified carbohydrate chains. To engineer the sensor chip, the team developed a smart surface with nano-cavities that fit the particular target glycoprotein.

To create the nano-cavities, the sugar part of the prostate cancer glycoprotein is reacted with a custom-designed molecule that contains a boron group at one end as the boron linkage forms a reversible bond to the sugar. The other end of this custom molecule is made to react with molecules that have been tethered to a gold surface. The glycoprotein is then bound to the surface via its sugar groups, before the rest of the surface is blocked with a third molecule. When the glycoprotein is removed by breaking the reversible boron bonds it leaves behind a perfect cast. Within that cast, there was a special area with boron-containing molecules that can recognize a specific set of sugars. Surface plasmon resonance (SPR) analyses were performed at 25 °C with the Dual Channel SPR Spectrometer (Reichert, Buffalo, NY, USA).

John S. Fossey, PhD, a senior lecturer and a coauthor of the study, said, “It's estimated that one in eight men will suffer from prostate cancer at some point in their life, so there's a clear need for more accurate diagnosis. By focusing on the sugar, we appear to have hit the ‘sweet spot’ for doing just that. Our focus now is to take this technology and develop it into something accessible to people across the world. We believe that this could be applicable to other diagnostic challenges. Lots of diseases produce specific glycoproteins, so there are a number of possible avenues to improve the accuracy of our diagnoses.” The study was published on June 17, 2015, in the journal Chemical Science.

Related Links:

University of Birmingham
Reichert


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more